Drug Information

Drug General Information
Drug ID
D08LJJ
Former ID
DNC011737
Drug Name
6-Bromo-2-(2-nitro-phenyl)-chromen-4-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [551336]
Formula
C15H8BrNO4
Canonical SMILES
C1=CC=C(C(=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)Br)[N+](=O)[O-]
InChI
1S/C15H8BrNO4/c16-9-5-6-14-11(7-9)13(18)8-15(21-14)10-3-1-2-4-12(10)17(19)20/h1-8H
InChIKey
GXUSNZYZTBJMIT-UHFFFAOYSA-N
PubChem Compound ID
44298955
Target and Pathway
Target(s) Gamma-aminobutyric acid receptor subunit alpha-1 Target Info Inhibitor [551336]
Gamma-aminobutyric acid receptor Target Info Inhibitor [551336]
KEGG Pathway Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
GABAergic synapse
Morphine addiction
Nicotine addiction
Reactome Ligand-gated ion channel transport
GABA A receptor activation
WikiPathways SIDS Susceptibility Pathways
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
Iron uptake and transport
References
Ref 5513366-Bromo-3??nitroflavone, a new high affinity benzodiazepine receptor agonist recognizes two populations of cerebral cortical binding sites, Bioorg. Med. Chem. Lett. 7(3):373-378 (1997).
Ref 5513366-Bromo-3??nitroflavone, a new high affinity benzodiazepine receptor agonist recognizes two populations of cerebral cortical binding sites, Bioorg. Med. Chem. Lett. 7(3):373-378 (1997).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.